Regulatory, financial and ethical aspects of routine clinical magnetic resonance spectroscopy | Zendy

Alger Jeffry R. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Regulatory, financial and ethical aspects of routine clinical magnetic resonance spectroscopy

Author(s) -

Alger Jeffry R.

Publication year - 2000

Publication title -

nmr in biomedicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 114

eISSN - 1099-1492

pISSN - 0952-3480

DOI - 10.1002/1099-1492(200008)13:5<::aid-nbm650>3.0.co;2-1

Subject(s) - confusion , realm , perspective (graphical) , engineering ethics , medical physics , medicine , psychology , political science , computer science , law , engineering , artificial intelligence , psychoanalysis

After years of technological development, magnetic resonance spectroscopy (MRS) is now being used with increasing frequency as a routine diagnostic tool for medical evaluation of patients. The transition of MRS from the realm of pure research to that of routine clinical application has been accompanied by some confusion regarding regulatory, financial and ethical matters. This contribution summarizes these issues from the author's perspective and calls for increased discussion and learning within the MRS community regarding practical matters associated with routine clinical implementation of MRS. Copyright © 2000 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research